Skip to content
Presentation at the ESSM 2024 - Presentation at the SMSNA 2023 - Presentations at the WCE 2023 -
PELVIPHARM
  • Home
  • About us
    • Our mission
    • Letter from the President
    • Our platforms
    • Our certifications
    • Staff
    • Our Partners
  • Services
  • Publications
  • News
  • Contact us

OGER S.,BEHR-ROUSSEL D.,GORNY D.,CHARTIER-KASTLER E.,VALIDIRE P., ALEXANDRE L., GIULIANO F

Combined effect of a phosphodiesterase 5 inhibitor, udenafil, with an antimuscarinic, oxybutynin on human detrusor relaxation
ICS, Neurol Urodyn 2009.

Posted in Publications, Publications Meeting Abstracts, Urology - meeting and Abstract
© 2024 PELVIPHARM - Legal notices

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Scroll To Top
PELVIPHARM
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.